Background
Methods
Technical approach
Results
Variables | PE+
n = 25 | PE−
n = 50 |
p
|
---|---|---|---|
Age, years, median (IQR) | 66 (74-57) | 63 (75-52) | 0,393 |
Gender/Male, no. of patients | 16 (64%) | 34 (68%) | 0,797 |
Comorbidities, no. of patients | 18 (72%) | 35 (70%) | 0,858 |
Heart disease, no. of patients | 13 (52%) | 30 (60%) | 0,509 |
Kidney disease, no. of patients | 3 (12%) | 6 (12%) | 1,000 |
Liver disease, no. of patients | 2 (8%) | 4 (8%) | 1,000 |
Cancer, no. of patients | 1 (4%) | 1 (2%) | 1,000 |
Metabolic disease, no. of patients | 4 (16%) | 10 (20%) | 0,763 |
Respiratory disease, no. of patients | 2 (8%) | 4 (8%) | 1,000 |
Cerebral disease, no. of patients | 6 (24%) | 11 (22%) | 0,881 |
Ulcer size, mm, median (IQR) | 152 (400-79) | 127 (225-79) | 0,737 |
Forrest IA, no. of patients | 5 (20%) | 11 (22%) | 0,937 |
Forrest IB, no. of patients | 4 (16%) | 7 (14%) | 0,937 |
Forrest IIA, no. of patients | 11 (44%) | 22 (44%) | 0,937 |
Forrest IIB, no. of patients | 5 (20%) | 10 (20%) | 0,937 |
HGB, g/dl, median (IQR) | 8,2 (11-7) | 8,7 (10-5,8) | 0,482 |
ERY, ×1012/L, median (IQR) | 2,7 (3,5-2,1) | 2,9 (3,7-2,1) | 0,727 |
INR, ratio, median (IQR) | 1,07 (1,25-1) | 1,16 (1,34-1) | 0,318 |
Shock index, median (IQR) | 0,93 (1,2-0,67) | 0,86 | 0,567 |
Rockall score, points, median (IQR) | 6 (5-7) | 6 | 0,608 |
Scores | PE+
n = 25 | PE−
n = 50 |
p
|
---|---|---|---|
Rockall score 3 | 3/12% | 7/14% | 1.000 |
Rockall score 4–5 | 4/16% | 11/22% | 0.761 |
Rockall score 6–7 | 13/52% | 21/42% | 0.412 |
Rockall score 8–9 | 4/16% | 10/20% | 0.763 |
Rockall score 10–11 | 1/4% | 1/2% | 1.000 |
Shock index 0,1 > | 0/0 | 3/6% | 0.546 |
Shock index 0,5 > | 6/24% | 12/24% | 1.000 |
Shock index 0,7 > | 9/36% | 15/30% | 0.600 |
Shock index 1 > | 10/40% | 20/40% | 1.000 |
Drugs | PE+
n = 25 | PE−
n = 50 |
p
|
---|---|---|---|
Anticoagulants | 2/8% | 5/10% | 1.000 |
Antiaggregants | 6/24% | 13/26.5% | 0.814 |
NSAID (excluding Aspirine) | 3/12% | 12/24% | 0.359 |
Outcomes | PE+ | PE− |
p
|
---|---|---|---|
ICU needed | 25 (100%) | 40 (82%) | 0,024 |
ICU stay, days, median (IQR) | 3 (3-2) | 3 (5-2) | 0,352 |
Transfusion needed, no of patients | 22 (88%) | 40 (80%) | 0,524 |
PRBC, units | 4 (5-3) | 4 (5-2) | 0,399 |
FFP, units, (IQR) | 2 (2-2) | 3 (4-2) | 0,013 |
Surgery, no of patients | 2 (8%) | 17 (35%) | 0,012 |
Re-bleeding, no of patients | 3 (12%) | 11 22,4% | 0,358 |
Hospital stay, days (IQR) | 6 (10-6) | 9 (11-6) | 0,079 |
Mortality, no of patients | 1 (4%) | 8 16,3% | 0,258 |